These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33827287)

  • 1. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.
    Ray JG; Vermeulen MJ; Schull MJ; Park AL
    Clin Appl Thromb Hemost; 2021; 27():10760296211008986. PubMed ID: 33827287
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Nauka PC; Baron SW; Assa A; Mohrmann L; Jindal S; Oran E; Glazman-Kuczaj G; Southern WN; Chekuri S
    Thromb Res; 2021 Mar; 199():82-84. PubMed ID: 33476901
    [No Abstract]   [Full Text] [Related]  

  • 3. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Choi JJ; Wehmeyer GT; Li HA; Alshak MN; Nahid M; Rajan M; Liu B; Schatoff EM; Elahjji R; Abdelghany Y; D'Angelo D; Crossman D; Evans AT; Steel P; Pinheiro LC; Goyal P; Safford MM; Mints G; DeSancho MT
    Thromb Res; 2020 Dec; 196():318-321. PubMed ID: 32977130
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
    Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19.
    Kow CS; Hasan SS
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):114-115. PubMed ID: 32933883
    [No Abstract]   [Full Text] [Related]  

  • 6. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
    Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
    ;
    Anaesthesia; 2022 Jan; 77(1):28-39. PubMed ID: 34428858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in the era of COVID-19.
    Kyriakoulis KG; Kokkinidis DG; Kyprianou IA; Papanastasiou CA; Archontakis-Barakakis P; Doundoulakis I; Bakoyiannis C; Giannakoulas G; Palaiodimos L
    Phlebology; 2021 Mar; 36(2):91-99. PubMed ID: 33249999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
    Loo J; Spittle DA; Newnham M
    Thorax; 2021 Apr; 76(4):412-420. PubMed ID: 33408195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism.
    Stefely JA; Christensen BB; Gogakos T; Cone Sullivan JK; Montgomery GG; Barranco JP; Van Cott EM
    Am J Hematol; 2020 Dec; 95(12):1522-1530. PubMed ID: 32833259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism in COVID-19 infection.
    Honkanen M; Sirkeoja S; Viskari H; Kailankangas V; Sinisalo M; Syrjänen J
    Intern Med J; 2023 Aug; 53(8):1478-1480. PubMed ID: 37449583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Thrombosis and Thromboembolism in COVID-19.
    Poor HD
    Chest; 2021 Oct; 160(4):1471-1480. PubMed ID: 34153340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism and COVID-19: a case report and review of the literature.
    Bhatt H; Singh S
    J Med Case Rep; 2020 Oct; 14(1):188. PubMed ID: 33054805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications.
    Kollias A; Kyriakoulis KG; Stergiou GS; Syrigos K
    Br J Haematol; 2020 Aug; 190(4):529-532. PubMed ID: 32621757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection.
    Figueira Gonçalves JM; Golpe R
    Med Clin (Barc); 2020 Aug; 155(4):162-164. PubMed ID: 32475616
    [No Abstract]   [Full Text] [Related]  

  • 18. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex.
    Shusterman M; Golub E; Mowrey WB; Broder A
    Lupus; 2018 Feb; 27(2):319-326. PubMed ID: 28705035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study.
    De Giorgi A; Contini C; Greco S; Fabbian F; Gasbarro V; Zuliani G; Passaro A; Zenunaj G; Manfredini R
    J Infect Dev Ctries; 2021 May; 15(5):639-345. PubMed ID: 34106886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing trials on COVID-19 treatments: please, don't forget Venous Thromboembolism!
    Zuin M; Zuliani G; Rigatelli G; Roncon L
    J Thromb Thrombolysis; 2021 May; 51(4):1170-1171. PubMed ID: 33386562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.